For research use only. Not for therapeutic Use.
Sacubitril-d4(CAT: C000325) is a deuterium-labeled derivative of Sacubitril. Sacubitril itself is a pharmaceutical compound used in cardiovascular medicine. It acts as a neprilysin inhibitor, which helps increase the levels of beneficial peptides like natriuretic peptides while reducing the degradation of these peptides. In pharmaceutical chemistry, Sacubitril, and its deuterium-labeled counterpart are essential in drug development, particularly for the treatment of heart failure.
Catalog Number | C000325 |
CAS Number | 1884269-07-1 |
Synonyms | [S-(R*,S*)]-[1,1′-Biphenyl]-4-pentanoic Acid,γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-Ethyl Ester-d4; |
Molecular Formula | C₂₄H₂₅D₄NO₅ |
Purity | ≥95% |
Target | Neprilysin |
Solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
Appearance | Colourless to Pale Yellow Gel to Solid |
Storage | 4°C |
Reference | McMurray, J., et al.: N. Eng. J. Med., 371 (2014); |